HCA
AVNS icon

Horan Capital Advisors’s Avanos Medical AVNS Stock Holding History

Horan Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-125
Closed -$4K – 100
2020
Q3 		$4K Buy
+125
New +$3.99K ﹤0.01% 279

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Horan Capital Advisors's AVNS Position: Q4 2020 in Review

Horan Capital Advisors sold out of Avanos Medical (AVNS) in Q4 2020, closing a stake of 125 shares — an estimated $4K sold.

Horan Capital Advisors first reported a position in AVNS in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Horan Capital Advisors reported no remaining Avanos Medical position as of Q4 2020 after selling out during the quarter.
  • Horan Capital Advisors sold 125 Avanos Medical shares in Q4 2020, an estimated $4K.
  • Horan Capital Advisors first reported a position in Avanos Medical in Q3 2020 and held it in 1 quarter.
  • Horan Capital Advisors's Avanos Medical position peaked at $4K in Q3 2020.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.